Sionna Therapeutics, Inc.
SION
$37.17
-$0.15-0.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.72M | 24.16M | 19.80M | 16.33M | 13.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.98M | 83.50M | 87.68M | 77.07M | 70.56M |
| Operating Income | -88.98M | -83.50M | -87.68M | -77.07M | -70.56M |
| Income Before Tax | -75.27M | -70.68M | -75.84M | -66.32M | -61.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -75.27 | -70.68 | -75.84 | -66.32 | -61.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.27M | -70.68M | -75.84M | -66.32M | -61.69M |
| EBIT | -88.98M | -83.50M | -87.68M | -77.07M | -70.56M |
| EBITDA | -88.34M | -82.84M | -87.04M | -76.41M | -69.89M |
| EPS Basic | -1.95 | -4.87 | -10.08 | -12.38 | -15.60 |
| Normalized Basic EPS | -1.22 | -3.04 | -6.30 | -7.73 | -9.75 |
| EPS Diluted | -1.95 | -4.87 | -10.08 | -12.38 | -15.60 |
| Normalized Diluted EPS | -1.22 | -3.04 | -6.30 | -7.73 | -9.75 |
| Average Basic Shares Outstanding | 159.60M | 119.66M | 79.89M | 38.93M | 15.42M |
| Average Diluted Shares Outstanding | 159.60M | 119.66M | 79.89M | 38.93M | 15.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |